Liu Kaiheng, Liu Wenjuan, Dong Zirong, Zhang Luyu, Li Qiuyu, Zhang Renjie, He Haisheng, Lu Yi, Wu Wei, Qi Jianping
Key Laboratory of Smart Drug Delivery of MOE, School of Pharmacy Fudan University Shanghai China.
Bioeng Transl Med. 2022 Sep 7;8(2):e10405. doi: 10.1002/btm2.10405. eCollection 2023 Mar.
Ionic liquids (ILs) attract more and more interests in improving drug transport across membrane, including transdermal, nasal, and oral delivery. However, some drawbacks of ILs impede the application in oral drug delivery, such as rapid precipitation of poorly soluble drugs in stomach. This study aimed to employ enteric mesoporous silica nanoparticles (MSNs) to load ILs to overcome the shortcomings faced in oral administration. The choline sorbate ILs (SCILs) were synthesized by choline bicarbonate and sorbic acid and then adsorbed in mesopores of MSNs after dissolving cyclosporin A (CyA). MSNs loading SCILs and CyA were coated by Eudragit® L100 to form enteric nanoparticles. The in vitro release study showed that the CyA and SCILs released only 10% for 2 h in simulated gastric fluids but more than 90% in simulated intestinal fluid. In addition, SCILs and CyA were able to release from MSNs synchronously. After oral administration, enteric MSNs loading SCILs were capable of improving oral absorption of CyA significantly and the oral bioavailability of CyA was similar with that of oral Neoral®. In addition, the oral absorption of enteric MSNs was higher than that of nonenteric MSNs, which showed that enteric coating was necessary to ILs in oral delivery. These findings revealed great potential of translation of ILs to be enteric nanoparticles for facilitating oral absorption of CyA. It is predictable this delivery system is promising to be a platform for delivering poorly water-soluble drugs and even biologics orally.
离子液体(ILs)在改善药物跨膜转运方面越来越受到关注,包括经皮、鼻腔和口服给药。然而,离子液体的一些缺点阻碍了其在口服药物递送中的应用,例如难溶性药物在胃中迅速沉淀。本研究旨在利用肠溶介孔二氧化硅纳米颗粒(MSNs)负载离子液体,以克服口服给药中面临的缺点。通过胆碱碳酸氢盐和山梨酸合成胆碱山梨酸盐离子液体(SCILs),然后在溶解环孢素A(CyA)后将其吸附在MSNs的介孔中。负载SCILs和CyA的MSNs用Eudragit® L100包衣以形成肠溶纳米颗粒。体外释放研究表明,CyA和SCILs在模拟胃液中2小时仅释放10%,但在模拟肠液中释放超过90%。此外,SCILs和CyA能够同步从MSNs中释放。口服给药后,负载SCILs的肠溶MSNs能够显著提高CyA的口服吸收,且CyA的口服生物利用度与口服Neoral®相似。此外,肠溶MSNs的口服吸收高于非肠溶MSNs,这表明在口服给药中对离子液体进行肠溶包衣是必要的。这些发现揭示了将离子液体转化为肠溶纳米颗粒以促进CyA口服吸收的巨大潜力。可以预见,这种递送系统有望成为口服递送难溶性药物甚至生物制品的平台。